Anti-Rab3A (phospho T86) antibody [MJF-R46-4] - BSA and Azide free
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal RAB3A phospho T86 antibody. Carrier free. Suitable for WB, Dot and reacts with Transfected cell lysate - Human, Synthetic peptide - Human samples.
View Alternative Names
Ras-related protein Rab-3A, RAB3A
- WB
Collaborator
Western blot - Anti-Rab3A (phospho T86) antibody [MJF-R46-4] - BSA and Azide free (AB316305)
This data was developed using ab316304, the same antibody clone in a different buffer formulation.
Goat anti-Rabbit IgG Secondary Antibody used at 1 : 25, 000.
Anti-HA High Affinity from rat IgG1 used at 1 : 5000 (28KDa).
Data was kindly provided by collaborator.
Exposure time : Not provided.
All lanes:
Western blot - Anti-Rab3A (phospho T86) antibody [MJF-R46-4] (<a href='/en-us/products/primary-antibodies/rab3a-phospho-t86-antibody-mjf-r46-4-ab316304'>ab316304</a>) at 1/1000 dilution
Lane 1:
HEK-293T cells transfected with a human RAB3A expression vector containing a HA-tag treated with 100nM MLi-2 for 90 minutes, whole cell lysate at 20 µg
Lane 2:
Untreated HEK-293T cells transfected with a human RAB3A expression vector containing a HA-tag, whole cell lysate at 20 µg
Lane 3:
HEK-293T cells transfected with a human RAB3B expression vector containing a HA-tag treated with 100nM MLi-2 for 90 minutes, whole cell lysate at 20 µg
Lane 4:
Untreated HEK-293T cells transfected with a human RAB3B expression vector containing a HA-tag, whole cell lysate at 20 µg
Lane 5:
HEK-293T cells transfected with a human RAB3C expression vector containing a HA-tag treated with 100nM MLi-2 for 90 minutes, whole cell lysate at 20 µg
Lane 6:
Untreated HEK-293T cells transfected with a human RAB3C expression vector containing a HA-tag, whole cell lysate at 20 µg
Lane 7:
HEK-293T cells transfected with a human RAB3D expression vector containing a HA-tag treated with 100nM MLi-2 for 90 minutes, whole cell lysate at 20 µg
Lane 8:
Untreated HEK-293T cells transfected with a human RAB3D expression vector containing a a HA-tag, whole cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG Secondary Antibody at 1/25000 dilution
Observed band size: 28 kDa
false
- WB
Supplier Data
Western blot - Anti-Rab3A (phospho T86) antibody [MJF-R46-4] - BSA and Azide free (AB316305)
This data was developed using ab316304, the same antibody clone in a different buffer formulation.
Dot blot analysis of Rab3A (phospho T86) using ab316304 at 1 : 1000 (0.513 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
All lanes:
Western blot - Anti-Rab3A (phospho T86) antibody [MJF-R46-4] (<a href='/en-us/products/primary-antibodies/rab3a-phospho-t86-antibody-mjf-r46-4-ab316304'>ab316304</a>) at 1/1000 dilution
Lane 1:
Rab3A non-phospho peptide
Lane 2:
Rab3A (phospho T86) peptide a
Lane 3:
Rab3A (phospho T68) peptide b
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-Rab3A (phospho T86) antibody [MJF-R46-4]
Reactivity data
Product details
ab316305 is the carrirer-free version of ab316304.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Rab3A facilitates neurotransmitter release by interacting with effector proteins such as RIM and Rabphilin-3A. It is part of a larger complex that includes the SNAREs which help mediate synaptic vesicle fusion. Through its regulatory action Rab3A ensures that neurotransmitters are released in a controlled manner during synaptic transmission which is essential for proper neuronal communication.
Pathways
Rab3A participates in the synaptic vesicle cycle which is vital in neurotransmitter release. This cycle involves key proteins like Syntaxin and VAMP. Rab3A interacts with these SNARE proteins to participate in vesicle docking and priming. Additionally it plays a role in the calcium-dependent exocytosis pathway which relies on calcium ions triggering vesicle fusion at nerve terminals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com